期刊文献+

维生素D受体基因ApaI和TaqI位点多态性与帕金森病的相关性研究 被引量:4

Association of vitamin D receptor gene polymorphisms with Parkinson disease
原文传递
导出
摘要 目的探讨维生素D受体(vitaminDreceptor,VDR)基因ApaI和TaqI位点多态性与帕金森病(Parkinson’sdisease,PD)遗传易感性的相关性。方法采用聚合酶链反应一限制性片段长度多态性技术和基因测序方法,检测285例中国北方汉族散发PD患者与285名正常对照VDR基因ApaI和TaqI位点多态性,并比较两组基因型和等位基因频率的差异。结果A抛I和TaqI位点基因型和等位基因频率在PD组和对照组之间差异均无统计学意义(P〉0.05)。将样本按性别及发病年龄分组后比较,ApaI位点各亚组间基因型频率和等位基因频率差异亦无统计学意义(P〉0.05),而TaqI位点的基因型分布在男性PD组(168例)与男性对照组(160名)之间差异有统计学意义(X2=4.187,P=0.032,OR=2.149,95%cI:1.011~4.567),男性PD组T等位基因频率较男性对照组显著增高(X2=3.867,P=0.036,OR=2.064,95%CI:0.989~4.307)。结论VDR基因A加I位点多态性与PD风险间无相关性,但TaqI可能是男性PD的风险因素。 Objective Vitamin D receptor (VDR) has been proposed as a candidate gene for susceptibility to Parkinson's disease (PD). This study was set to assess the association between VDR gene Apa I and Taq I polymorphisms and PD in a Chinese Han population. Methods Two hundred and eighty- five sporadic PD patients and 285 healthy controls were genotyped for the Apa I and Taq I polymorphisms in VDR gene using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Results No significant difference was detected in genotype or allele distribution of both Apa I and Taq I polymorphisms between PD patients and controls (P^0.05). No TT genotype for Taq I was found in the studied population. For Taq I , the distribution of genotype was significantly different between male PD patients and controls ( 2=4.187, P= 0.032, 0R:2.149, 95%CI:1.011-4.567), and the frequency of T allele was significantly higher in male PD patients than male controls (X2= 3. 867, P=0. 036, OR= 2.064, 95%CI:0. 989-4. 307). Conclusion VDR gene Apa I polymorphisms are not associated with sporadic Parkinson's disease, hut Taq I may be a risk factor for male PD.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2013年第1期13-16,共4页 Chinese Journal of Medical Genetics
关键词 维生素D受体 帕金森病 单核苷酸多态性 Vitamin D receptor Parkinson's disease Single nucleotide polymorphisms
  • 相关文献

参考文献18

  • 1Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease. Neurology, 2009, 72(21 Suppl 4) :S1-136.
  • 2Newmark HI., Newmark J. Vitamin I) and Parkinson's disease-- a hypothesis. Mov Disord, 2007, 22:461-468.
  • 3Smolders J, Moen SM, I)amoiseaux J, et healthy and inflamed central nervous function. J Neurol Sci, 2011, 311:37-43.
  • 4Butler MW, Burt A, Edwards TL, el al system: access the and l) receptor Ann Hum Motory and Parkinson disease group, Division of Neurological disease, Chinese Medical Association, Diagnosis of Parkinson' s diease. Chin J Neurol, 2006, 39:408-409.
  • 5Li JH, (?hen [)M, I.i Z, et al. Study on association hetwecn vitamin 1) receptor gene poLymorphisms and the outcomes of HP, V infection. Chin J Med Gcnet, 2006, 86:1952 1956.
  • 6Habuchi T, Suzuki T, Sasaki R, el al. Association of vitamin I) receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res, 2000, 60:305-308.
  • 7Gareion E, Wion-Barbot N, Montero Menei CN, et al.' New clues about vitamin 10 functions in the nervous system. "]'rends Endocrinol Metab, 2002, 13 : 100-105.
  • 8Knekt P, Kilkkinen A, Rissanen H, et al. Serum vitamin D and the risk of Parkinson disease. Arch Neurol, 2010, 67:808- 811.
  • 9Suzuki M, Yoshioka M, Hashimoto M, et al. 25 hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease. Mov Disord, 2012, 27 : 264-271.
  • 10Suzuki M, Yoshioka M, Hashimoto M, et al. 25 hydroxyvitamin D, vitamin I) receptor gene polymorphisms, and severity of Parkinson's disease. Mov l)isord, 2012, 27 : 264-271.

同被引文献47

  • 1Loreffilt B, Toss G, Granfirus AK. Bone mass in elderly pa- tients with Parkinson: s disease[J]. Acta Neurol Scand, 2007, 116(4) :248-254.
  • 2Evatt ML, Delong MR, Kumari M, et al. High prevalence of hypovitaminosis D status in patients with early Parkinson dis- ease[J]. Arch Neurol,2011,68(3) :314-319.
  • 3Fyfe I. Parkinson disease Reduced leve| o:[ dietary vitamin D is associated with PD[J]. Nat Rev Neurol, 2015,11 (2) : 68.
  • 4Peterson AL, Mancini M, Horak FB. The relationship between balance control and vitamin D in Parkinson' s disease-a pilot study[J]. Mov Disord,2013,28(8) : 1133-1137.
  • 5Meamar R, Maracy M, Chitsaz A, et al. Association betweenserum biochemical levels, related to bone metabolism and Par- kinson: s disease[J]. J Res Med Sci, 2013, 18 (Suppl. 1) $39-$42.
  • 6Sato Y, Honda Y, Nail M, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson: s disease patients with vitamin D deficiency[J]. Bone, 2002, 31 ( 1 ) : 114 118.
  • 7Lin WP, Wen CJ, Jiang CC, et al. Risk factors for hip fracture sites and mortality in older adults[J]. J Trauma,2011,71 (1): 191-197.
  • 8Ding H, Dhima K,Lockhart KC, et al. Unrecognized vitamin D3 deficiency is common in Parkinson disease: harvard biomar- ker study[J].Neurology,2013,81(17) : 1531 1537.
  • 9Sato Y, lwamoto J, Honda Y. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in Parkinson' s disease[J]. Parkinsonism Rel Dis,2011,17(1):22-26.
  • 10Hitz MF, Jensen JE, Eskildsen PC. Bone mineral density and bone markers in patients with a recent low-energy fracture: effect of 1 y of treatment with calcium and vitam in D[J]. Am J Clin Nutr,2007,86(1) :251 259.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部